Millions of people around the world have benefited from the use of GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro to lose weight and combat obesity.
But anecdotal evidence shows that coming off the medication and readjusting to life can often be difficult, with many experiencing rapid weight gain and reversal of heart and diabetes risk markers.
